The pharmaceutical company is evaluating all options to increase its presence in therapy areas, including in-licensing ...

Takeda (TSE:4502/NYSE:TAK) today announced that applications are now open for its Innovators in Science Award. This prestigious global award, originally launched in 2016, celebrates groundbreaking ...

A new study is the first phase 3 to show meaningful improvement in both progression-free and overall survival with first-line ...

NEWARK, CA / ACCESS Newswire / May 21, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or the “Company”) today announced ...

A class of older drugs used to treat type 2 diabetes may also help slow the progression of prostate cancer, a small study ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Salesforce is charging up its Life Sciences Cloud by joining forces with Takeda and deepening ties with Informatica to ...

Those data centers that are equipped to handle AI processing loads are projected to require $5.2 trillion in capital ...

Dan Gandor, an omnichannel ace who has spent his entire career on the client side of the business, has joined Eversana ...

Takeda joins a growing list of leading pharmaceutical and biotech companies to leverage Life Sciences Cloud for Customer Engagement, a solution designed to unify data and engagement across the entire ...

Takeda is organized around five core businesses: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for over 80% of revenue. It also has a developing ...